Review
Multiple Switches in G Protein-Coupled Receptor Activation

https://doi.org/10.1016/j.tips.2009.06.003Get rights and content

The activation mechanism of G protein-coupled receptors has presented a puzzle that finally may be close to solution. These receptors have a relatively simple architecture consisting of seven transmembrane helices that contain just a handful of highly conserved amino acids, yet they respond to light and a range of chemically diverse ligands. Recent NMR structural studies on the active metarhodopsin II intermediate of the visual receptor rhodopsin, along with the recent crystal structure of the apoprotein opsin, have revealed multiple structural elements or ‘switches’ that must be simultaneously triggered to achieve full activation. The confluence of several required structural changes is an example of “coincidence counting”, which is often used by nature to regulate biological processes. In ligand-activated G protein-coupled receptors, the presence of multiple switches may provide an explanation for the differences between full, partial and inverse agonists.

Introduction

G protein-coupled receptors (GPCRs) are integral membrane proteins that respond to light (rhodopsin-like receptors) and a diverse array of chemical signals. Common features of these receptors are that they have seven transmembrane helices and activate intracellular G proteins. Despite the cellular and pharmacological importance of GPCRs, it has been a challenge to establish how the seven transmembrane helix structure recognizes and responds to such a large and diverse set of ligands. One of the first insights into how these receptors are activated came from site-directed spin labeling studies using electron paramagnetic resonance (EPR) spectroscopy on the visual pigment rhodopsin that revealed a large outward rotation of transmembrane helix H6 [1]. Crosslinking of helices H3 and H6 demonstrated that this motion was required for formation of the G-protein binding site on the intracellular surface of the receptor 1, 2. In 2000, the first of several crystal structures of rhodopsin 3, 4, 5 and its photoreaction intermediates 6, 7 was reported (Figure 1a). More recently, the crystal structures of several ligand-activated GPCRs have been solved using different methods to stabilize inactive receptor conformations 8, 9, 10. Because the transition to the active receptor appears to require a fluid membrane environment to accommodate an appreciable change in receptor structure, it has been a challenge to obtain high-resolution structures of active GPCRs.

In the past year, the landscape has shifted with the reported crystal structure of the apoprotein opsin 11, 12 and nuclear magnetic resonance (NMR) structural studies of the active metarhodopsin II intermediate (meta II) 13, 14 (Figure 2). The structural information that emerges from NMR and protein crystallography is extremely complementary. The NMR studies have focused on structural changes on the extracellular side of the receptor caused by retinal isomerization. The NMR data show that the second extracellular loop (EL2), which is wedged between two of the transmembrane helices (H3 and H6), is displaced upon activation (Figure 1b). The opsin structure lacks the agonist all-trans retinal chromophore on the extracellular side of the receptor, but retains elements of the active structure on the intracellular side of the receptor. Importantly, it captures the outward rotation of H6 and demonstrates that this creates the binding site for the C terminus of the Gα subunit of transducin (Figure 1c). The picture that emerges is that EL2 is a regulatory element that prevents the outward rotation of the intracellular end of H6, perhaps by preventing the inward pivoting of the extracellular end of H6 as envisioned by the global toggle switch mechanism [15].

This simple “clothes-pin” model is not adequate to fully describe the activation mechanism. In addition, the intracellular ends of helices H3 and H6 are clamped together by an ionic lock between Arg1353.50 on H3 and Glu2476.30 on H6 16, 17. What has not been clear until recently is how this lock is released. The combination of NMR and X-ray crystallography provides an answer. Retinal isomerization displaces EL2 from the retinal-binding site. The motion of EL2 is tightly coupled to the reorientation of helices H5, H6 and H7. On the intracellular side of H5 and H7 are two conserved tyrosines, Tyr2235.58 on H5 and Tyr3067.53 on H7. The coordinated motion of H5-H7 places these tyrosines between the intracellular ends of helices H3 and H6 disrupting the ionic lock 11, 12.

In this review, we first describe the multiple structural “switches” in rhodopsin that trigger the conformational changes involved in activation and formation of the G-protein binding site. We then draw parallels with ligand-activated GPCRs, for which the occurrence of multiple switches may explain the structural differences between full, partial and inverse agonists 18, 19. The concept of molecular switches extends the concept of structural motifs as functional microdomains developed by Weinstein and colleagues [20] who identified several conserved motifs in GPCRs that mediate receptor function.

Section snippets

Rhodopsin activation is triggered by retinal isomerization and Schiff base deprotonation

Rhodopsin is unique among the GPCRs in having a covalently bound chromophore that functions as an inverse agonist in the dark and is rapidly converted to a full agonist by light. The 11-cis retinal chromophore in rhodopsin is attached to Lys2967.43 through a protonated Schiff base (PSB) linkage and locks the visual receptor in an inactive conformation. The first structural change or switch in the activation process involves isomerization of retinal to the all-trans configuration and

Parallels between rhodopsin and ligand-activated GPCRs

Rhodopsin is unique in being activated by a covalently bound retinal chromophore rather than by the binding of a diffusible ligand. However, rhodopsin is similar to ligand-activated GPCRs in containing roughly 14 sites in the helices that are highly conserved and 14 sites that are ‘group-conserved’ across the class A family of GPCRs [32]. Within this conserved framework are regions that are subfamily-specific and have evolved to recognize or to respond to specific ligands. The occurrence of

Concluding remarks and future challenges

The recent crystal structures obtained of opsin and NMR studies on the active meta II intermediate allow one to follow the structural changes triggered by retinal isomerization on the extracellular side of rhodopsin to breaking of the ionic lock on the intracellular side. The activation mechanism provides an explanation for many, if not all, of the highly conserved residues in the transmembrane helices and reveals how the important structural motifs and functional microdomains are connected.

Acknowledgements

S.O.S. was supported by a grant from the National Institutes of Health (RO1-GM41412).

Glossary

Ballesteros-Weinstein generic numbering
the amino acid numbering used in this review incorporates the residue number from the amino acid sequence of the specific receptor being discussed and a residue number from a generic numbering system developed by Ballesteros and Weinstein to facilitate the comparison of residues between different receptors. The sequence number is placed after the residue name, for example, Trp265 corresponds to a conserved tryptophan at position 265 in bovine rhodopsin,

References (61)

  • L. Shi

    β2 adrenergic receptor activation - Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch

    J. Biol. Chem.

    (2002)
  • E. Crocker

    Location of Trp265 in metarhodopsin II: Implications for the activation mechanism of the visual receptor rhodopsin

    J. Mol. Biol.

    (2006)
  • S. Madabushi

    Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions

    J. Biol. Chem.

    (2004)
  • T.J. Baranski

    C5a receptor activation - Genetic identification of critical residues in four transmembrane helices

    J. Biol. Chem.

    (1999)
  • Z.L. Lu et al.

    The functional topography of transmembrane domain 3 of the M-1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis

    J. Biol. Chem.

    (1999)
  • F.J. Bartl

    Partial agonism in a G protein-coupled receptor: Role of the retinal ring structure in rhodopsin activation

    J. Biol. Chem.

    (2005)
  • M. Han

    Partial agonist activity of 11-cis-retinal in rhodopsin mutants

    J. Biol. Chem.

    (1997)
  • M.E. Olah

    Role of the 2nd extracellular loop of adenosine receptors in agonist and antagonist binding - Analysis of Chimeric A1/A3-adenosine receptors

    J. Biol. Chem.

    (1994)
  • M. Conner

    Systematic analysis of the entire second extracellular loop of the V-1a vasopressin receptor - Key residues, conserved throughout a G-protein-coupled receptor family, identified

    J. Biol. Chem.

    (2007)
  • J.L. Baneres

    Molecular characterization of a purified 5-HT4 receptor - A structural basis for drug efficacy

    J. Biol. Chem.

    (2005)
  • C.S. Sum

    Two arginine–glutamate ionic locks near the extracellular surface of FFAR1 gate receptor activation

    J. Biol. Chem.

    (2009)
  • C.D. Strader

    Identification of two serine residues involved in agonist activation of the β-adrenergic receptor

    J. Biol. Chem.

    (1989)
  • C. Ambrosio

    Different structural requirements for the constitutive and the agonist-induced activities of the β2 adrenergic receptor

    J. Biol. Chem.

    (2005)
  • S. Bhattacharya

    Ligand-stabilized conformational states of human β2 adrenergic receptor: Insight into G-protein-coupled receptor activation

    Biophys. J.

    (2008)
  • G. Swaminath

    Probing the β2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists

    J. Biol. Chem.

    (2005)
  • C.E. Elling

    Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation

    J. Biol. Chem.

    (2006)
  • C. Prioleau

    Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor - Identification of a novel “locked-on” phenotype and double revertant mutations

    J. Biol. Chem.

    (2002)
  • D.L. Farrens

    Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin

    Science

    (1996)
  • S.P. Sheikh

    Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F

    Nature

    (1996)
  • K. Palczewski

    Crystal structure of rhodopsin: A G protein-coupled receptor

    Science

    (2000)
  • Cited by (103)

    • Lepidoptera: Female sex pheromone biosynthesis and its hormonal regulation

      2020, Insect Pheromone Biochemistry and Molecular Biology
    • Molecular aspects of delta opioid receptors

      2019, Vitamins and Hormones
      Citation Excerpt :

      The tryptophan residue within this motif is by far the most documented. Referred to as the “tryptophan switch” or the “aromatic lock,” its replacement normally impedes the activity of the receptor (Ahuja & Smith, 2009; Holst et al., 2010). Finally, the NP(x)2Y(x)6F motif of DOP includes residue Asn314 which, as mentioned above, is part of the conserved polar network inside the receptor and therefore plays an important role in stabilizing the protein.

    View all citing articles on Scopus
    View full text